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Introduction
There is substantial literature supporting the view that the 
lower incidence of cardiovascular disease (CVD) in premeno-
pausal women compared with age-matched male counter-
parts and postmenopausal women (1, 2) suggests that female 
sex underlies a protective effect on the cardiovascular system 
(for reviews, see refs. 3, 4) — an effect that has been linked to 
an action of ovarian hormones, predominantly estrogens (for 
reviews, see refs. 5, 6). However, the exact target and molecular 
pathways that underlie the beneficial effects of female sex in 
humans has remained uncertain.
Most chronic CVD is characterized by endothelial dysfunc-
tion thought to be a consequence of an underlying systemic 
inflammation manifested as many of the symptoms associated 
with abnormal vascular regulation, including blood pressure 
dysregulation, inadequate tissue perfusion, capillary edema, 
and inflammatory cell recruitment. These changes ultimate-
ly lead to disease, including hypertension and atherosclerosis. 
Indeed, strong correlations between systemic markers of inflam-
mation and inflammation of the arteries with increased risk for 
cardiovascular events have been demonstrated (7, 8). Likewise, 
endothelium dysfunction and event risk, disease prognosis, 
and disease severity are strongly associated (9–11). Important-
ly, experimental models in humans have confirmed the link 
between inflammation and endothelial dysfunction (12). There 
is also preclinical evidence suggesting that reduced systemic 
inflammation associated with preserved endothelium function 
in females is associated with protection against chronic CVD, 
BACKGROUND. Cardiovascular disease occurs at lower incidence in premenopausal females compared with age-matched 
males. This variation may be linked to sex differences in inflammation. We prospectively investigated whether inflammation 
and components of the inflammatory response are altered in females compared with males.
METHODS. We performed 2 clinical studies in healthy volunteers. In 12 men and 12 women, we assessed systemic 
inflammatory markers and vascular function using brachial artery flow-mediated dilation (FMD). In a further 8 volunteers of 
each sex, we assessed FMD response to glyceryl trinitrate (GTN) at baseline and at 8 hours and 32 hours after typhoid vaccine. 
In a separate study in 16 men and 16 women, we measured inflammatory exudate mediators and cellular recruitment in 
cantharidin-induced skin blisters at 24 and 72 hours.
RESULTS. Typhoid vaccine induced mild systemic inflammation at 8 hours, reflected by increased white cell count in both 
sexes. Although neutrophil numbers at baseline and 8 hours were greater in females, the neutrophils were less activated. 
Systemic inflammation caused a decrease in FMD in males, but an increase in females, at 8 hours. In contrast, GTN response 
was not altered in either sex after vaccine. At 24 hours, cantharidin formed blisters of similar volume in both sexes; however, 
at 72 hours, blisters had only resolved in females. Monocyte and leukocyte counts were reduced, and the activation state 
of all major leukocytes was lower, in blisters of females. This was associated with enhanced levels of the resolving lipids, 
particularly D-resolvin.
CONCLUSIONS. Our findings suggest that female sex protects against systemic inflammation-induced endothelial 
dysfunction. This effect is likely due to accelerated resolution of inflammation compared with males, specifically via 
neutrophils, mediated by an elevation of the D-resolvin pathway.
TRIAL REGISTRATION. ClinicalTrials.gov NCT01582321 and NRES: City Road and Hampstead Ethics Committee: 11/LO/2038.
FUNDING. The authors were funded by multiple sources, including the National Institute for Health Research, the British 
Heart Foundation, and the European Research Council.
Accelerated resolution of inflammation underlies  
sex differences in inflammatory responses in humans
Krishnaraj S. Rathod, Vikas Kapil, Shanti Velmurugan, Rayomand S. Khambata, Umme Siddique, Saima Khan, Sven Van Eijl, 
Lorna C. Gee, Jascharanpreet Bansal, Kavi Pitrola, Christopher Shaw, Fulvio D’Acquisto, Romain A. Colas, Federica Marelli-Berg,  
Jesmond Dalli, and Amrita Ahluwalia
William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, United Kingdom.
Conflict of interest: A. Ahluwalia is a director of Heartbeet Ltd.
License: This work is licensed under the Creative Commons Attribution 4.0 International 
License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Submitted: July 18, 2016; Accepted: October 17, 2016.
Reference information: J Clin Invest. 2017;127(1):169–182. doi:10.1172/JCI89429.
Downloaded from http://www.jci.org on January 12, 2017.   https://doi.org/10.1172/JCI89429
The Journal of Clinical Investigation C L I N I C A L  M E D I C I N E
1 7 0 jci.org   Volume 127   Number 1   January 2017
of typhoid vaccine–induced endothelial dysfunction (12) (study 1) 
and cantharidin-induced blister formation (20) (study 2) in male 
and female healthy volunteers (Figure 1).
Results
Baseline data for study 1 and 2 demonstrated that the volunteers 
were well matched in terms of age. Expected differences were 
observed in BMI, systolic blood pressure (SBP), and diastolic 
blood pressure (DBP) (Table 1).
Typhoid vaccine induces a low-grade systemic inflammation in 
both males and females. Typhoid vaccination resulted in a rise in 
circulating leukocyte numbers in both sexes due almost entirely to 
a neutrophilia (Table 2), as per previous reports (12). Interestingly, 
it is notable that at baseline the numbers of wbc trended to higher 
values in females versus males. The differential counts demon-
strate that this difference is due to greater numbers of neutrophils 
in females (P < 0.05); all other circulating cell numbers at baseline 
were similar between the sexes. Use of flow cytometry, to assess 
the relative activation state of the circulating cells, demonstrated 
that at baseline the expression of key adhesion molecules involved 
in inflammatory cell recruitment (CD11b, CD162, and CD62L) was 
particularly in models of atherosclerosis (for review, see ref. 
13). Moreover, there is evidence predominantly from preclinical 
assessment that sex influences immune responses particularly 
with respect to the consequence of infection (14)
In accord with the above suggestions, using intravital 
microscopy we recently observed that leukocyte recruitment in 
response to cytokine IL-1β or TNF-α is reduced in female mice 
compared with age-matched male mice (8). This effect likely 
reflects an overall decrease in reactivity of the microvascula-
ture in females, since the responses to two distinct proinflam-
matory cytokines were similarly suppressed. In addition, these 
findings are in agreement with studies from a range of animal 
models of inflammation, suggesting the existence of sex hor-
mone–dependent male/female differences in inflammatory 
cell recruitment (15–19). However, whether similar pathways 
govern reduced inflammatory responses in humans is unknown 
and an issue we have aimed to address herein.
To test whether sex differences in inflammatory responses 
and pathways might underlie preserved endothelial function in 
females, we assessed both vascular and inflammatory responses 
in the systemic and local inflammation using the validated models 
Figure 1. Flow charts of clinical studies. (A) Study 1. (B) Study 2. 
PWV, pulse wave velocity; PWA, pulse wave analysis; FMD, flow- 
mediated dilatation.
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Sex differences in the vascular response to typhoid vaccination. 
Baseline ultrasound flow-mediated dilatation (FMD) responses 
were similar between the sexes; however, while typhoid vaccine 
tended to decrease the vascular response in males, in females 
the FMD response increased. This profile of FMD response was 
significantly different between the sexes, with the greatest differ-
ence evident at the 8-hour time point (P < 0.01; Figure 3, A and 
B). These changes were evident despite no change over time in 
baseline diameter or in the time taken to reach peak diameter 
following release of the cuff (Supplemental Table 2). Evidence 
suggests that the FMD response is due predominantly to trigger-
ing of endothelium-dependent NO generation. To assess whether 
this might underlie differences in the sexes, we measured nitrite 
and nitrate (NOx) levels. We found no significant differences in 
circulating NOx levels between the time points; however, interest-
ingly post hoc correlation analyses demonstrated that circulating 
nitrite concentrations correlate directly with the magnitude of 
the FMD response in females but not males (Supplemental Fig-
ure 2). In contrast to FMD, typhoid vaccination did not alter the 
vasodilation response to sublingual GTN in either sex (Figure 3, 
C and D) and did not influence pulse wave velocity (PWV) or aug-
mentation index through pulse wave analysis (PWA). Since the 
largely similar between the sexes, except for an elevation in expres-
sion of activation markers on circulating monocytes in females 
(Supplemental Figure 1; supplemental material available online 
with this article; doi:10.1172/JCI89429DS1). Following typhoid 
vaccine, the activation state of circulating neutrophils relative to 
baseline was enhanced in males but not females, specifically with 
elevations of CD162 and CD62L (Figure 2), both cellular adhesion 
molecules that play a pivotal role in cell homing, rolling, and adhe-
sion in an inflammatory scenario (21, 22) — an effect only evident 
on neutrophils and not on other cell types (Supplemental Figure 
1). There were no measurable changes from baseline in platelet 
reactivity in either sex and at any of the time points tested (Sup-
plemental Table 1). Circulating levels of C-reactive protein (CRP) 
and body temperature were not altered by typhoid vaccine (Table 
2). To determine whether differences in the systemic inflammato-
ry response might relate to differences in vaccine administration 
between the sexes, we assessed typhoid (IgM) antibody titers at 32 
hours following vaccination. Our data showed no statistical differ-
ences in the antibody response (male: 10.4 ± 1.8 U/ml, n = 11 and 
female: 11.4 6 ± 1.6 U/ml, n = 10), suggesting that the above dif-
ferences in systemic inflammation relate to biological differences 
between the sexes in the response to an inflammatory stress.
Table 1. Demographics of healthy volunteers in study 1 and 2
Study 1: typhoid Study 2: cantharidin
Male Female P Male Female P
Volunteers (n) 12 12 16 16
Age (yr) 26.0 ± 5.7 24.7 ± 6.8 0.59 27.4 ± 1.1 26.8 ± 1.1 0.68
BMI (kg/m2) 24.8 ± 3.2 21.8 ± 2.9 0.021 24.6 ± 0.7 22.4 ± 0.6 0.019
Baseline SBP (mmHg) 119.5 ± 1.8 107.5 ± 2.4 0.0005 115.7 ± 2.0 104.1 ± 1.7 0.0001
Baseline DBP (mmHg) 65.6 ± 3.0 67.6 ± 1.2 0.55 68.3 ± 1.7 64.6 ± 1.5 0.12
Heart rate (bpm) 69.4 ± 2.8 65.7 ± 2.6 0.36 64.1 ± 2.3 68.4 ± 1.7 0.15
Oral contraceptive – 4  – 6
Data are shown as mean ± SEM with statistical significance determined using Student’s 2-tailed unpaired t test.
Table 2. Body temperature, blood differentials and CRP levels in male and female healthy volunteers at baseline and at 8 and 24 hours 
after typhoid vaccination
Time point Temperature (°C) Hb (g/dl) Platelets (×109/l) wbc (×1011/l) Neutrophils (×109/l) Lymphocytes (×109/l) Monocytes (×109/l) CRP (mg/l)
Male
Baseline 36.0 ± 0.1A 14.8 ± 0.3A 223.4 ± 14.8 5.5 ± 0.2 2.9 ± 0.7 1.9 ± 0.4 0.5 ± 0.2 <5
8 hours 35.9 ± 0.1B 14.5 ± 0.4B 223.6 ± 14.9 8.0 ± 0.5C 5.2 ± 1.5D 2.1 ± 0.4 0.6 ± 0.2 <5
32 hours 35.9 ± 0.1A 14.7 ± 0.4A 235.0 ± 15.0 5.5 ± 0.3 3.0 ± 1.1 1.9 ± 0.4 0.4 ± 0.2 <5
Female
Baseline 36.2 ± 0.1 13.3 ± 0.3 251.3 ± 12.0 6.7 ± 0.4 4.3 ± 1.3 2.2 ±0.4 0.4 ± 0.1 <5
8 hours 36.1 ± 0.1 13.1 ± 0.2 255.8 ± 11.2 9.2 ± 0.6D 6.5 ± 2.0E 2.2 ± 0.4 0.6 ± 0.2 <5
32 hours 36.2 ± 0.1 13.0 ± 0.2 249.0 ± 12.1 6.3 ± 0.3 3.7 ± 1.0 2.2 ± 0.4 0.5 ± 0.2 <5
















Data are shown as mean ± SEM with statistical significance comparing the responses over time between the sexes determined using 2-way ANOVA shown 
as a numerical, with post hoc comparisons using Šídák’s tests represented by  AP < 0.01 and BP < 0.05 for male versus female; CP < 0.0001, DP < 0.001, and 
EP < 0.01, for within-group versus baseline comparison.
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observations are in line with other published studies (20, 24, 25), 
providing evidence that this is indeed a safe, reliable, and repro-
ducible technique to study acute inflammation.
Within the cantharidin-induced blister, we found significant-
ly lower edema in females compared with males (Figure 4A). 
Indeed, at the 72-hour time point, blisters had completely resolved 
in 11 females (70%) in comparison to only 5 males (using a 4 by 
2 contingency table, the χ2 test demonstrated a significant differ-
ence between the sexes; P < 0.0019). While there was no signif-
icant difference (albeit a trend) in the total number of cells or in 
the number of neutrophils recruited into the blisters between the 
sexes (Figure 4, B and C), assessment of levels of other key inflam-
matory cell types and cell activation state exposed a prominent 
difference between the sexes (see Supplemental Figure 3 for typ-
ical scatter plots). In females the proportions and total numbers 
of inflammatory monocytes were significantly reduced compared 
with blisters from male volunteers, particularly at 72 hours (Fig-
ure 3D). Of note, there were also significantly lower levels of CD4+ 
and CD8+ T cells in females when compared with males at both 
the 24- and 72-hour time points. There were no differences in 
the numbers of either the intermediate monocyte or the resident 
monocyte subtype (see Supplemental Figures 4 and 5).
PWV and PWA are measures of arterial compliance determined 
predominantly by smooth muscle function (Supplemental Table 
2), the data collectively suggest that the differences seen in the 
FMD response to typhoid vaccination were not due to underlying 
changes in smooth muscle reactivity.
Sex differences in cantharidin-induced inflammation. To explore 
more closely whether differences in inflammatory cells between 
males and females observed with typhoid vaccination might reflect 
sex-based differences in acute inflammatory responses, we used a 
validated cantharidin-based model of inflammation (20, 23). We 
chose this model since there is no noninvasive method in vivo to 
explore organ-specific cell and humoral components; therefore, 
we moved to an easily accessible organ-based model using skin 
inflammation. Cantharidin application at the time points assessed 
was not associated with a systemic inflammatory response in either 
sex, as reflected by the lack of change from baseline in peripher-
al blood markers of systemic inflammation, such as CRP, leuko-
cyte count, and leukocyte differential (Supplemental Table 3). 
All volunteers reported that the typhoid vaccine caused minimal 
discomfort beyond the injection and that the cantharidin blisters 
were pain free other than an itching and/or tingling sensation a few 
hours after cantharidin application as the blisters formed. These 
Figure 2. Low-grade systemic inflammation induced by typhoid vaccination enhances neutrophil activation state in healthy male but not female 
volunteers. Changes in expression of (A) CD11b, (B) CD162, and (C) CD62L on neutrophils in male and female healthy volunteers at baseline, 8 hours, and 
32 hours following typhoid vaccine administration. Changes in expression of (D) CD11b, (E) CD162, and (F) CD62L from baseline in male and female healthy 
volunteers at 8 hours and 32 hours following typhoid vaccine administration. Data expressed as mean ± SEM of n = 12 male and female volunteers for all 
the panels. Statistical significance determined using 2-way ANOVA with Šídák’s post hoc analysis; *P < 0.05 for all panels.
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pro-resolving mediators (SPM) levels were elevated in female 
blister exudates when compared with those obtained from males 
(sum of all of the SPMs significantly greater in females, 17.2 ± 7.4 
pg/50 μl [SD] than males, 10.5 ± 6.3 pg/50 μl; P = 0.015), with par-
ticularly the D-series resolvin levels collectively demonstrating a 
significant increase in females compared with males (Figure 6C). 
In these exudates we also found significantly higher levels of the 
potent leukocyte chemoattractant LTB4 in male exudates when 
compared with female exudates (Figure 6D), thus indicating that 
female-derived exudates gave an overall pro-resolving lipid medi-
ator profile when compared with male exudates (Figure 6E). To 
determine whether similar differences were evident in volunteers 
subjected to typhoid vaccination, we assessed the levels of lipid 
mediators in plasma from volunteers 8 hours following vaccina-
tion, the time point at which the differences in endothelial func-
tion were most evident (Figure 3A). In plasma from these patients, 
we identified lipid mediators from all three major bioactive metab-
olomes, in accordance with published criteria (28). Multivariate 
analysis of lipid mediator profiles obtained using MRM gave two 
distinct clusters. Assessment of mediators that were associated 
with either of the clusters demonstrated that LTB4 was associat-
ed with the male cluster with a variable in importance score >1, 
whereas RvE1 and RvE3 were found to associate with the female 
clusters. Statistical analysis of each of the bioactive mediator fami-
lies demonstrated that in females, there was a significant decrease 
in the LTB4 metabolome and a significant upregulation of the 
E-series resolvins specifically, RvE1 and RvE3 (see Supplemental 
Figure 6 and Supplemental Table 6).
Discussion
It is accepted that premenopausal women have reduced levels 
of CVD compared with their age-matched counterparts (4). The 
exact mechanisms involved in mediating this protection are uncer-
tain but have been attributed to an effect of female sex hormones 
Interestingly, as shown in Figure 5, irrespective of whether 
there were differences in the absolute numbers of specific cell 
subtypes between the sexes, all cell types showed a substantially 
and significantly reduced expression of all 3 activation markers in 
females compared with males. In 24-hour blister samples, using 
a cytokine/chemokine bead array, we identified no differences 
between the sexes in the levels of the proinflammatory cytokines/
chemokines, which included IL-6, the neutrophil chemokines 
CCL5 and CXCL1, and the monocyte chemokine CCL2. Interest-
ingly, we found higher levels of IL-8 in the blisters from female 
volunteers compared with males and importantly a trend for high-
er expression of the antiinflammatory cytokine IL-10 in females 
(Supplemental Table 4).
Elevated levels of resolving mediators in female blister exudates. 
Since lipid mediators play an important role in both the initiation 
and the termination of acute inflammation (26, 27), we next pro-
filed lipid mediator levels in 24-hour blister exudates to inves-
tigate whether mediator levels from the three major bioactive 
metabolomes were differentially regulated between males and 
females. Using liquid chromatography–tandem mass spectrom-
etry (LC-MS/MS) we identified mediators from the arachidonic 
acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic 
acid (DHA) bioactive metabolomes, including leukotriene B4 
(LTB4), prostaglandin E2 (PGE2), resolvin D1 (RvD1), RvD2, 
RvD3, and protectin D1 (also known as PD1). These molecules 
were identified in accordance with published criteria (28), includ-
ing matching retention times and >6 diagnostic ions in the MS/MS 
to authentic or synthetic standards (Figure 6A). Multiple reaction 
monitoring (MRM) was used to quantify mediators in these blis-
ter exudates. Using orthogonal partial least squares discriminant 
analysis (OPLS-DA), distinct clusters for lipid mediator profiles in 
the exudates were evident between male and females (Figure 6B 
and Supplemental Table 5). Assessment of overall levels of each 
of the lipid mediator families demonstrated that the specialized 
Figure 3. Low-grade systemic inflammation 
induced by typhoid vaccination does not cause 
endothelial dysfunction in healthy female 
volunteers. The effect of typhoid vaccination 
on (A) FMD measured at baseline and 8 and 
32 hours following typhoid vaccination. (B)The 
effect of sex on the change in FMD at 8 hours 
following typhoid vaccination from baseline All 
data are expressed as mean ± SEM of n = 12 for 
each sex. Statistical significance determined 
using (A) 2-way ANOVA with Šídák’s post hoc 
analysis, **P < 0.01; and (B) Student’s 2-tailed 
unpaired test. Maximal dilatation of the 
brachial artery in response glyceryl trinitrate 
in (C) male and (D) female healthy volunteers 
measured at baseline and 8 and 32 hours 
following typhoid vaccination. Data expressed 
as mean ± SEM of n = 8. Statistical significance 
determined using 1-way ANOVA with Šídák’s 
post-hoc analysis.
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(5). Separately, we know that while women tend to experience 
increased autoimmune disease, they have lower rates of inflam-
mation in the context of chronic disease such as CVD and infec-
tion (29, 30). Since good evidence links innate immune responses 
with CVD (31) and inflammation is particularly thought to be caus-
ative in endothelial dysfunction (a critical pathogenic step in CVD 
progression), we speculated that reduced acute inflammatory 
responses in females may contribute to the protection of women 
against endothelial dysfunction and ultimately CVD development. 
Using experimental models to test this hypothesis in healthy vol-
unteers, we show that female sex protects against the endothelial 
dysfunction induced by a mild systemic inflammatory response 
and that this protection likely relates to an enhanced leukocyte 
surveillance in the female circulation and an accelerated resolu-
tion of inflammation. We speculate that this enhanced capacity 
to deal with and then recover from an inflammatory stress likely 
plays a crucial role in the reduced rates of inflammatory CVD in 
premenopausal females.
Administration of typhoid vaccine to healthy volunteers causes 
a transient endothelial dysfunction reflected by a reduced response 
to reactive hyperemia (12). In this study, the FMD response was 
reduced following typhoid vaccination in males, but in contrast, in 
females FMD was greater following vaccine administration. Com-
parison of the change in FMD from baseline between the sexes 
(the primary outcome) demonstrates a clear protection in females 
from the damaging effects of systemic inflammation induced here 
by typhoid vaccination. Since responses to the endothelium-inde-
pendent vasodilator GTN in both sexes were unchanged, nor were 
there any changes in arterial stiffness measures of PWV and PWA, 
these findings suggest that protection against the damaging effects 
of typhoid vaccination evident in females relates to alterations in 
endothelial function and not changes in smooth muscle reactivi-
ty. This latter observation agrees with previous findings demon-
strating no effect of typhoid vaccination upon NO donor-induced 
brachial artery dilator response to either sublingual GTN (12) or 
intra-arterial infusions of sodium nitroprusside (32).
Plasma nitrite is thought to reflect endothelial NO generation, 
and NO is considered to mediate at least in part the shear stress- 
induced FMD response (33–36). Post hoc correlation analyses 
show that while FMD responses in females correlated directly with 
circulating nitrite levels, there was no such relationship in males. 
The primary pathway implicated in upregulation of beneficial NO 
levels in health is phosphorylation of eNOS via an AKT-dependent 
pathway; and this pathway underlies estrogen-induced enhanced 
NO biovailability (37, 38). It is likely that this pathway is responsi-
ble for the enhanced FMD responses in this study. Interestingly, 
in preclinical studies it has been suggested that in blood vessels of 
female animals, estrogen-induced upregulation of the AKT/eNOS 
phosphorylation pathway is resistant to repression by pathological 
stimuli that cause profound endothelial dysfunction in males (39). 
Additionally, evidence also demonstrates an increased efficacy 
of stimuli activating the AKT pathway in females compared with 
males (40). Of relevance to this study, acute low-grade inflamma-
tion, while exerting proinflammatory pathways, also triggers reflex 
protective effects particularly through upregulating AKT phosphor-
ylation (41, 42). These observations together support the view that 
the enhanced FMD response in females following typhoid is likely 
secondary to a phosphorylation of eNOS resulting in greater shear 
Figure 4. Reduced inflammatory response to cantharidin in female compared with male healthy volunteers. The total (A) volume of fluid, (B) cell count, 
(C) neutrophil count, (D) inflammatory monocyte count, and (E) CD4+ and (F) CD8+ T cell count at 24 hours and 72 hours following application of cantharidin 
to the volar aspect of the forearm. Data is shown as mean ± SEM of n = 16 of each sex for all the panels. Statistical analysis was determined using 2-way 
ANOVA followed by Šídák’s post tests; #P < 0.05, ##P < 0.01 for all panels.
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stress–induced NO generation. The lack of a correlation between 
nitrite levels and FMD in males suggests that the FMD response in 
this sex is not entirely dependent upon NO (43). Indeed, the latter 
seems likely, since a recent meta-analysis of studies assessing the 
contribution of NO in mediating FMD estimated that 47%–67% 
of the response could be attributed to NO — the number varying 
according to the methodology used (43) but also possibly to the 
high inter-individual variability (44) — and now our data suggest 
that this also depends upon sex.
As expected, a number of demographic variables were distinct 
between the sexes despite being age-matched and healthy (45). 
These include BMI and blood pressure but also wbc count. The 
elevated wbc at baseline in females has been attributed to high-
er neutrophil numbers (46), and indeed in our study neutrophils 
accounted for the differences between men and women. Impor-
tantly, all women recruited into these studies attended experimen-
tal days at the midpoint of their menstrual cycles, when estrogen 
levels are generally at their highest and so also are the leukocyte 
and neutrophil counts (47) — the latter thought to be due to an 
action of estrogen. This raised wbc/neutrophil number in females 
may be due to estrogen-induced margination of neutrophils from 
the bone marrow. In healthy women asked to conduct controlled 
exercise, as a trigger for changes in granulocyte distribution, the 
response remained unchanged at different stages of the menstrual 
cycle (47). However, studies in mice suggest that low-dose estrogen 
inhibits rather than triggers bone marrow margination (48). Exact-
ly why these diametrically opposing results occur is uncertain, but 
they may simply reflect important species differences. Interesting-
ly, while we saw no significant differences in monocyte numbers at 
baseline, our data suggest a generalized raised activation state of 
circulating neutrophils and monocytes in females compared with 
males. In particular, we saw enhanced expression of both CD162 
and CD62L adhesion molecules on these cell types in men at 8 
hours, with recovery of baseline expression levels by 32 hours fol-
lowing typhoid vaccine, with no significant changes in expression 
levels in women. If anything there was some suggestion of a slight 
but nonsignificant decrease in females in the expression of the 
adhesion molecules relative to baseline. With respect to CD62L, 
it is possible that this reflects the shedding of CD62L that occurs 
during inflammatory responses and is thought to enhance leuko-
cyte transmigration (49); however, further experiments powered 
against CD62L levels are needed investigate this. In addition, both 
cellular CD162 and CD62L have been identified as critical media-
tors of the homing, rolling, and adhesion of both neutrophils and 
monocytes to sites of inflammation through interaction with the 
endothelium, and thus the enhanced cell expression in the males is 
likely to reflect an increased cell activation (21, 22).
Irrespective of which mechanisms might underlie the differ-
ences, the outcome of such a response would be to reduce expo-
sure of the vasculature to the potentially long-term detrimental 
effects of a sustained inflammatory response, and this offers a 
possible explanation for the absence of vascular dysfunction in 
the female sex. Interestingly, recent evidence suggests the sex dif-
ferences in leukocyte count and activation state evident in healthy 
volunteers are lost in individuals with raised CVD risk, although 
it is worth noting that the average age of the women in this par-
ticular study was 62, an age when the majority of the women are 
likely to have been postmenopausal (although whether this was 
the case is unclear) (50). Our observations in this systemic inflam-
mation model suggest that there is an enhanced surveillance and 
readiness to deal with inflammatory stimuli resulting ultimately 
in a reduced detrimental impact upon the vasculature. In order to 
probe the possible mechanisms further, we assessed inflammato-
ry responses using the cantharidin-based model of innate inflam-
matory response (20).
Cantharidin is a protein phosphatase 1 and 2 alpha inhibitor 
(51). When applied to the skin, it results in acantholysis and blister 
formation, which has been attributed to the detachment of tono-
filaments from desmosomes (52). This in turn causes leukocyte 
extravasation, cytokine release, and clinical inflammation. During 
inflammation, leukocytes and proteins traverse the blood vessel 
into the extravascular space. Recruitment of cells to inflammatory 
sites is dependent on the release of vasoactive and chemotactic fac-
tors that increase regional blood flow, increase microvascular per-
Figure 5. Reduced inflammatory cell activation state in cantharidin-induced blister exudates in female compared with male healthy volunteers. 
Mean fluorescence intensity (MFI) of the expression molecules CD162, CD62L, and CD11b on (A) neutrophils, (B) inflammatory monocytes, and (C) CD4+ 
and CD8+ T cells in healthy male (n = 16) and female (n = 16) volunteers. Data are shown as mean ± SEM. Statistical significances determined using 2-way 
ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; followed by Šídák’s post tests, #P < 0.05, ##P < 0.01, and ####P < 0.0001 comparing the 
sexes at each time point for all the panels.
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It is now accepted that the resolution of acute inflammation 
is an active process that is initiated when the very first leukocytes 
arrive at the inflammatory site. This process of resolution is trig-
gered by the recruited cells themselves and is mediated by a switch 
in the local production of lipid mediators from the proinflam-
matory eicosanoids, including prostaglandins and leukotrienes, 
to the pro-resolving and tissue-reparative SPMs, including the 
lipoxins and resolvins (26). Using targeted lipid mediator profil-
ing, we found a 1.4- to 2-fold-higher level for each class of SPMs in 
females. In addition, SPM amounts relative to those of the proin-
flammatory/chemotactic lipid mediator LTB4 exposed a SPMs/
LTB4 ratio in the females that was 3 times greater than in males, 
suggesting that the balance of pro-resolving to proinflammatory 
lipid mediators was tipped in favor of resolution in females. SPMs 
share a number of key defining bioactions, including their abili-
ty to limit neutrophil recruitment to the site, counterregulate the 
production and actions of proinflammatory mediators, and pro-
mote macrophage phagocytosis of cellular debris and apoptotic 
cells. In addition, each SPM displays unique biological actions; for 
example, MAR1 is produced in the later stages of the resolution 
phase and promotes tissue repair as well as displaying potent ant-
inociceptive actions. RvD1, RvD5, and PD1 are produced during 
self-limited infections and promote the clearance of bacterial 
infections, while resolvin D2 potently regulates endothelial NO 
production. In the present study, we found a significant reduction 
in both neutrophil and monocyte/macrophage activation state in 
females compared with males. This is in line with recent findings 
that demonstrate that RvD1 potently regulates neutrophil recruit-
ment and adhesion molecule expression (54), as well as with the 
finding that RvD1 regulates LTB4 formation by regulating 5-lip-
oxygenase phosphorylation and translocation to the nuclear 
membrane (57). This balance in favor of the resolving SPMs in the 
blisters of females compared with males was also evident in the 
plasma of females 8 hours following typhoid vaccine, supporting 
the view that active resolution is likely to underlie the protection 
against vascular dysfunction in females. Of note, in these plasma 
samples, we found an upregulation of molecules from the E-series 
resolvins that carry potent cardiovascular protective actions (58) 
The differential regulation of EPA- versus DHA-derived resolvins 
in plasma and inflammatory exudates may reflect the activation 
of different biosynthetic pathways by the different stimuli, in line 
with published findings (59), as well as a differential utilization of 
precursor fatty acids in plasma versus tissues (28, 60).
Interestingly, this pathway has also been proposed to be a tar-
get for sex steroid activity. Studies in vitro using whole blood and 
isolated neutrophils collected from healthy male and female vol-
unteers demonstrated that following stimulation with a proinflam-
matory stimulus, the levels of the 5-lipoxygenase products, includ-
ing LTB4, were reduced in males compared with females and that 
this effect related to activity of testosterone and the inhibition of 
nuclear localization of 5-lipoxygenase (61). Indeed, treatment of 
neutrophils collected from healthy women with 5-α-dihydrotes-
terone lowered the levels of 5-lipoxygenase products produced 
following stimulation to those evident in the cells isolated from 
males (61). Of note, treatment of neutrophils from donors of either 
sex with female sex hormones, 17β-estradiol or progesterone, did 
not alter the levels of the proinflammatory lipid mediators. How-
meability, and promote the exudation of leukocytes from the cir-
culation into the tissues (53). Cantharidin was used in this study to 
trigger this response to enable quantification of and therefore com-
parison between the sexes of this inflammatory response through 
assessment of the amount of fluid collecting into the blister, as well 
as characterizing the number and types of inflammatory cell col-
lecting within the exudate. In this study, cantharidin elicited blis-
ter responses in both males and females of a magnitude similar to 
that reported previously, in terms of edema (i.e., volume) and total 
number of cells (25). Indeed, at the 24-hour time point, the number 
of neutrophils, the first cell recruited to a site of inflammation, was 
very similar between the sexes, suggesting that female sex does not 
suppress the capacity to respond to an inflammatory stimulus per 
se. Assessment of the proinflammatory cytokine/chemokine pro-
file in the main supports this view. Our analyses suggest no differ-
ences between the sexes of some of the key mediators previously 
implicated in the cantharidin blister response in humans, including 
IL-6 (25), neutrophil (CXCL1, CCL5), and monocyte chemokines 
(CCL2) (54). However, at 72 hours there was a pronounced reduc-
tion in the blister volume, with a slight trend toward reduced cell 
numbers in females — a reduction accounted for by a pronounced 
and significant reduction in inflammatory monocyte numbers. 
Importantly, in many of the women (~70% vs. 30% in men), the 
blisters had resolved by 72 hours, resulting in no volume collection 
at all. Since the immediate (24-hour) response was similar between 
the sexes, we speculated that the reduced cell number and volume 
at 72 hours likely reflects an enhanced rate of resolution of inflam-
mation. This is in line with recent evidence demonstrating the 
key role of resolvins in clearing edema following an inflammatory 
insult, where edema in the lung induced in mice with hydrochlo-
ric acid was reduced by treatment with aspirin-trigged RvD3 (55). 
To explore this possibility, we assessed the level of IL-10, a pivotal 
cytokine released during the resolution stage of an inflammatory 
response that is derived from the antiinflammatory intermediate 
(M2) monocyte (56). We did observe a trend toward enhanced 
IL-10 in the blisters of females at 24 hours; however, this did not 
reach statistical significance, likely due to the fact that the study 
was not powered for this measurement. However, it is thought that 
IL-10 represses further cell recruitment in part by downregulating 
inflammatory cell activation. Indeed, the levels of CD62L, CD11b, 
and CD162 expression were all substantially reduced, supporting 
the view that while the response to the inflammatory stimulus was 
similar between the sexes, in females this inflammatory response 
was likely cleared and “resolved” at a much faster rate.
Figure 6. Female blister exudates display a pro-resolving mediator profile. 
Lipid mediators from exudates were extracted using C18 solid-phase 
extraction and profiled using LC-MS/MS–based lipid mediator profiling. (A) 
Representative multiple reaction monitoring chromatograms for identified 
lipid mediators and pathway markers from the 3 major bioactive metab-
olomes (left panel) and MS/MS spectra employed for their identification 
(right panel). (B) Partial least squares discriminant analysis of exudate lipid 
mediator profiles: left panel, 2D score plot; right panel, corresponding 2D 
loading plot. (C–E) Cumulative levels for the lipid mediator from the (C) doco-
sahexaenoic acid, (D) eicosapentaenoic acid, and (E) arachidonic acid SPMs, 
arachidonic acid–derived LTB4, and ratio of SPM to LTB4. Results shown are 
mean ± SEM of n = 11 females and n = 13 males for B–E. Statistical signifi-
cance determined using Students 2-tailed unpaired t test; *P < 0.05 for C–E.
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studies involving administration of an inflammogen. Female volun-
teers appointments were scheduled to fall at a maximum of 2 weeks 
and no less than 1 week prior to the due date of their next menstruation 
when estrogen levels at their highest.
All clinical studies were performed in a quiet temperature- 
controlled laboratory (24°C–26°C), and individuals were studied at the 
same time of day during the 3 days they were involved in the study 
period. Volunteers refrained from caffeine consumption and strenu-
ous exercise the day before and the day of the respective study, and 
were fasted overnight before all study visits.
Study 1: typhoid-induced systemic inflammation study. A total of 
24 healthy volunteers (12 males and 12 females) were consented for 
this 3-day study. On day 1 volunteers attended the clinic at 3 p.m. 
and measured their own blood pressure using a portable blood pres-
sure device. Body temperature was measured using a standard Braun 
Thermoscan Ear Thermometer. Following this, PWA, PWV, and FMD 
were determined. Blood was then collected. On day 2, the volunteers 
attended to receive the typhoid vaccination into the gluteal or deltoid 
region at 8 a.m. and returned at 3 p.m. for a repeat of all the previous 
measurements. On day 3, volunteers attended the clinic at 3 p.m. for 
the final time and had a final repeat of all measurements (Figure 1A). 
In a separate study, we recruited a further 16 healthy volunteers — 8 
males and 8 females — to assess endothelium-independent vasodila-
tion using glyceryl trinitrate (GTN) as per previous recommendations 
(63). Briefly, the volunteers attended the clinic as above but received 
a sublingual (0.4 mg) dose of GTN spray (Nitrolingual Pump Spray, 
Merck) in place of the reactive hyperemia stimulus. Whole blood dif-
ferentials and flow cytometry were measured to assess both leukocyte 
and platelet numbers and activation state, and plasma was collected 
for assessment of NOx levels and CRP.
Study 2: cantharidin-induced blister study. A total of 32 healthy vol-
unteers (16 male and 16 female) were consented for this 4-day study. 
On day 1, the volunteers measured their own blood pressure using a 
portable blood pressure device. After this, cantharidin solution was 
applied to the ventral aspect of a forearm. Blood was then collected. 
On day 3 (48 hours after the initial cantharidin application), volunteers 
returned to have cantharidin applied to a separate area, no less than 
5 cm away from the initial site. Finally, on day 4 (72 hours after the 
initial cantharidin application), the volunteers measured their blood 
pressure again, and then blister fluid was sampled from both blisters, 
and blood, urine, and saliva samples were collected. Blister fluid vol-
ume, cell count, flow cytometric analysis of cell type and activation 
state, and cytokine/chemokine analysis were also run.
For the application of cantharidin solution, 10 μl cantharidin 
(cantharone 0.1%, Dormer Laboratories) was applied to filter paper 
discs and placed on the ventral aspects of the forearm as previously 
described (48–51) and dressed appropriately. Blister fluid was then 
harvested at 24 hours (acute phase) and 72 hours (resolution phase) 
by carefully piercing the side of the blister with a 25-gauge needle and 
rolling a pipette tip over the surface of the blister to express blister flu-
id, which was then collected in a siliconized pipette; the fluid was then 
stored on ice until further analysis.
Blood sampling. Blood was collected into EDTA tubes for differen-
tial count analysis conducted by St. Bartholomew’s Hospital Haema-
tology Department. A further 4 ml of blood was collected in 1.8 mg 
EDTA per ml of blood for NOx measurement, and another 4 ml in 
3.2% buffered sodium citrate for aggregation assays and platelet flow 
ever, it is worth noting that for cells collected from female donors, 
the addition of female sex hormones in vitro may not have been 
effective since the cells will have been exposed to physiological 
levels of these hormone in vivo.  Furthermore, because the levels 
of 5-lipoxygenase were low at baseline in cells of male donors, it is 
unlikely that with in vitro treatment they would be further inhib-
ited. Treatment with additional 5-α-dihydrotesterone had no fur-
ther effect in cells isolated from males, suggesting likelihood of 
this hypothesis. Exactly why in our studies we saw higher SPM/
LTB4 ratios in females while in the study mentioned above high-
er ratios were evident in males is uncertain, but this may reflect 
the difference between in vivo and in vitro assessment, and fur-
ther investigation is warranted. Additionally, further studies 
exploring the regulation of SPM receptors on inflammatory cells 
themselves and the impact of inhibiting SPM formation on reso-
lution of inflammatory responses, as well as studies assessing the 
impact of raising SPM levels, are important to confirm the sexual 
dimorphism described but also to ascertain whether delivery of 
SPMs, particularly through dietary provision of substrate (27, 62), 
might offer a therapeutic approach that could be useful in limiting 
inflammatory responses.
Limitations. There are a number of limitations of our work. 
First, both models of inflammation provide an approximation of 
the systemic and local inflammatory scenarios. It is possible that 
the specific cellular profile induced by typhoid or cantharidin are 
not the same as those induced in a CVD scenario.
Since a large number of female blisters had resolved at the 
72-hour time point, a full profile of the resolution time course was 
not possible. Future experiments including a time point midway 
between 24 and 72 hours might provide a more detailed window 
on the time course of the resolution between the sexes. In addi-
tion, recording of the time of resolution in males would also pro-
vide an improved comparison of the time scale between the sexes.
Conclusions. We have demonstrated that the damaging effects 
of systemic inflammatory stimuli on the vasculature are limited 
in females and that this may be due to a more rapid resolution of 
the local inflammatory response. Strategies directly targeting res-
olution may be useful in limiting the damaging effects associated 
with the raised systemic inflammation that is characteristic of ear-
ly pathogenesis in CVD.
Methods
Volunteers. Equal numbers of male and female volunteers were recruit-
ed. Volunteers were included if they fulfilled the following inclusion 
criteria: 18–45 years of age, BMI of 18–40 kg/m2, and no typhoid 
vaccination in the previous 2 years. Exclusion criteria included: sub-
jects with a history of hypertension, diabetes, or hypertensive on BP 
measurement; subjects who were pregnant or any possibility that a 
subject may be pregnant, unless in the latter case a pregnancy test is 
performed with a negative result; subjects with a history of any seri-
ous illnesses, including recent infections or trauma; subjects taking 
systemic medication (other than the oral contraceptive pill); subjects 
with self-reported use of mouthwash or tongue scrapes; subjects with 
recent or current antibiotic use; subjects with a history or recent treat-
ment (within the preceding 3 months) of any oral condition (excluding 
caries), including gingivitis, periodontitis, and halitosis; and subjects 
who have recently participated (preceding 3 months) in any clinical 
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cocyanin and a CD62P (P-selectin;  catalog MCA883F, AbD Serotec) 
monoclonal antibody conjugated to fluorescein isothiocyanate, which 
was used to determine the P-selectin expression. Isotype controls for 
CD62P and CD42b were used to ensure antibody specificity. Samples 
were incubated at room temperature for 20 minutes with PBS, ADP (3 
μmol/l or 10 μmol/l; Labmedics), and collagen (1 μg/ml or 3 μg/ml; 
Takeda) before fixing with 1% paraformaldehyde (Sigma-Aldrich) and 
analyzed with the use of a Becton Dickinson LSR Fortessa Cell Ana-
lyzer. A total of 10,000 platelets were acquired in the CD42b-positive 
region. Results were expressed as the percentage of platelets positive 
for P-selectin (69).
Platelet-monocyte aggregate expression. Platelet-monocyte aggre-
gates were determined with the use of a modification of previously 
published protocols with antibodies that were selective for platelet 
CD42b, and monocyte marker CD14 (catalog 55397, BD Biosciences) 
samples were analyzed with the use of a Becton Dickinson LSR Fortes-
sa Cell Analyzer. Isotype controls were conducted.
Platelet aggregation. Platelet aggregation was assessed in whole 
blood in response to collagen (1–3 μg/ml), ADP (3 or 10 μM), and PBS 
(as control) using an impedance aggregometer (Multiplate analyzer, 
Dynabyte Medical) measured over a 6-minute period. Aggregation 
was quantified as AUC, giving a measure of total resistance Ω * time. 
Briefly, 300 μl of citrated whole blood was added to 300 μl of normal 
saline with 3 mM CaCl2 (Sigma-Aldrich) and equilibrated with con-
stant magnetic stirring for 3 minutes prior to addition of agonist and 
platelet aggregation measurement.
Inflammatory cell cytometry. The systemic inflammatory response 
at baseline and after typhoid vaccination was assessed using flow 
cytometry. Whole citrated blood (50 μl) was incubated with specific 
monoclonal antibodies conjugated to fluorochromes to identify lym-
phocytes, monocytes, and neutrophils (CD14, CD16 catalog 555407, 
CD16b catalog 550868, BD Biosciences; CD3 catalog 11-0039-42, 
CD4 catalog 25-0049-42, CD8 catalog 45-00988-42, eBioscience), 
as well as for determination of cell activation state via measurement 
of the expression of CD162 (catalog 17-1629-42), CD62L (catalog 
47-0629-42, eBioscience), and CD11b (catalog 558123, BD Biosci-
ence) (and their isotype controls) on the cell surface. Samples were 
mixed gently and then allowed to incubate for 30 minutes before 
removal of excess antibody with PBS and centrifugation for 5 minutes, 
400 g at 4°C. After decanting the supernatant, whole blood lysing 
reagent (Beckman Coulter) was added to each tube. After giving each 
tube a thorough vortex, a formaldehyde-containing fixative agent was 
added. The samples were washed twice using PBS and centrifuged 
for 5 minutes, 400 g at 21°C. Finally, 1% paraformaldehyde (Sigma- 
Aldrich) was added to the tubes. All samples were then analyzed using 
a Becton Dickinson LSR Fortessa Cell Analyzer and recorded with BD 
FACSDiva software.
For blister fluid prior to flow cytometry a total cell count was deter-
mined using a hemocytometer. The fluid was then centrifuged for 5 
minutes, 400 g at 4°C. After decanting the supernatant, the leukocyte 
pellet was resuspended in FACS buffer to ensure between 50,000 and 
100,000 cells/20 μl. 20 μl of the resuspended cells were then incubat-
ed with monoclonal antibodies and analyzed as above.
Lipid mediator profiling. Standards for LC-MS/MS profiling were 
purchased from Cayman Chemical or provided by Charles N. Serhan 
(Harvard Medical School, Boston, Massachusetts, USA; supported 
by NIH-funded P01GM095467). Blister exudates or plasma samples 
cytometry. All blood was collected into Vacutainers (BD Biosciences) 
through a 21-gauge butterfly needle inserted into an antecubital vein. 
For measurement of NOx levels, blood samples were centrifuged 
immediately (1,300 g, 4°C, 10 minutes), and the supernatant was col-
lected and stored at –80 °C pending analysis by ozone chemilumines-
cence as previously described (64, 65).
Blood pressure measurement. Blood pressure was measured at base-
line to confirm healthy volunteer status. An Omron 705IT was used 
for all BP measurements while participants were seated, and readings 
were performed in triplicate according to established guidelines (66). 
Laminated coverings were used for the machine and the printer so that 
both investigators and participants were blinded to the readings. The 
means of the second and third readings were used to calculate the final 
BP measurement.
PWV and PWA measurements. A Vicorder device (Skidmore Med-
ical Ltd.) was used to simultaneously record the pulse wave from the 
carotid and femoral sites using an oscillometric method. A small, inflat-
able neck pad is placed directly over a single carotid artery and secured 
around the neck by a Velcro tab. A cuff is placed around the subject’s 
ipsilateral upper thigh. Both carotid and femoral cuffs are inflated 
automatically to 65 mmHg, and the corresponding oscillometric signal 
from each cuff is digitally analyzed to extract the pulse time delay. The 
distance between the sternal notch and the thigh cuff is measured and 
used as a standard estimate for the aortic length. From these measure-
ments aortic PWV can be derived as PWV = aortic distance/pulse time 
delay (67). PWA was measured as follows: After 5-minute supine rest, 
a 100-mm inflatable cuff was attached to the non-dominant arm and 
statically inflated to 65 mmHg. Brachial artery waveforms were digital-
ly computed by Vicorder using a volume-displacement method for at 
least 10 cardiac cycles to calculate augmentation index.
Measurement of brachial artery diameter. Brachial artery diameter 
in the non-dominant arm was measured with high-resolution external 
vascular ultrasound (Acuson 128XP/10 with a 7.0-MHz linear array 
transducer). The vessel was scanned in longitudinal section, and the 
center was identified when the clearest views of the anterior and pos-
terior artery walls had been obtained. Images were magnified with a 
resolution box function and gated with the R wave of the ECG. End- 
diastolic images of the artery were acquired every 3 seconds with cus-
tomized data acquisition software and stored in digital format offline 
for later analysis (34). Brachial artery diameter was measured continu-
ously for 1 minute at baseline, during 5 minutes of reduced blood flow 
(induced by inflation to 300 mmHg of a pneumatic cuff placed at a 
site distal to the segment of artery being analyzed), and for a further 
5 minutes during reactive hyperemia after cuff release. Brachial artery 
diameter and brachial artery dilation expressed as percentage and 
absolute increase from baseline diameter and time to peak dilatation 
were determined using the software Vascular Analysis Tools (Medical 
Imaging Applications LLC).
Measurement of antibody titer. Plasma samples taken at baseline 
and at 32 hours after typhoid were analyzed for antibody titer using a 
commercially available kit (Typhoid Vi IgM ELISA kit; Alpha Diagnos-
tic International) as per the manufacturer’s instructions.
Platelet flow cytometry. Whole blood flow cytometry was used 
to measure platelet P-selectin with the use of a modification of pre-
viously published protocols and recommendations (68). The platelet 
population was identified via labeling with a CD42b (1:25; catalog 
11-0429-71, eBioscience) monoclonal antibody conjugated to allophy-
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were added to 2 volumes of ice-cold MeOH containing deuterated 
internal standards (d4-LTB4, d8-5S-HETE, d4-PGE2, d5-LXA4, and 
d5-RvD2, 500 pg each). These were then kept at –20°C for 45 min-
utes to allow for protein precipitation and subjected to solid-phase 
extraction as per ref. 28. Methyl formate fractions were then brought 
to dryness using a TurboVap LV (Biotage) and products suspend-
ed in water-methanol (50:50 vol/vol) for LC-MS/MS. A Shimadzu 
LC-20AD HPLC and a Shimadzu SIL-20AC autoinjector, paired with a 
QTrap 5500 (ABSciex) were utilized and operated as described previ-
ously (28). To monitor each lipid mediator and respective pathways, an 
MRM method was developed with diagnostic ion fragments and iden-
tification using recently published criteria (28), including matching 
retention time to synthetic and authentic materials and at least 6 diag-
nostic ions for each lipid mediator. Calibration curves were obtained 
for each using authentic compound mixtures and deuterium-labeled 
lipid mediator at 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, 100, and 200 pg. 
Linear calibration curves were obtained for each lipid mediator, which 
gave r2 values of 0.98–0.99. All measurements were conducted in a 
blinded manner.
Cytokine/chemokine analysis. Cytokine/chemokine expression 
profiles were analyzed using a customized bead array (IDEXX Pro-
Cyte Dx Hematology Analyzer) to measure IL-6, IL-8, IL-10, CXCL1, 
CXCL2, CCL5, and CCL2. All measurements were conducted in a 
blinded manner.
Power and statistical analysis. Based upon previous observations 
demonstrating typhoid vaccine–induced endothelial dysfunction (12). 
The primary outcome measure was change in % FMD, with an expect-
ed difference between the sexes of 1.5% and an SD of 1.5. Twelve sub-
jects in each group were required to achieve 80% power.
For the cantharidin study, based upon previous observations 
demonstrating that cantharidin triggers a total cell response of 0.6 
× 106 cells/ml with an SD of 0.2 (70) and in preclinical models where 
leukocyte recruitment was reduced by 50% in females (8), with a 
power of 0.9 a total of 12 individuals are required for each sex for 
statistical power. However, due to the limited sample size available 
for all analyses, we prespecified an n = 16 for each group to enable 
sufficient independent samples to assess soluble mediators. Where 
n values shown are less than 16, this is due to insufficient sample size 
for full analysis.
Data are shown as mean ± SD. Comparisons between the sexes 
have been made using unpaired 2-tailed t tests or 2-way ANOVA as 
appropriate. With respect to the latter, post hoc comparisons were 
made if the F statistic achieved P < 0.05 and there was no significant 
variance in homogeneity between groups using Holm-Šídák’s multiple 
comparison tests. For multivariate statistical analysis, OPLS-DA (71) 
was performed using SIMCA 13.0.3 software (Umetrics) following unit 
variance scaling of linear model (LM) amounts. OPLS-DA is based on 
a linear multivariate model that identifies variables that contribute to 
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